BAYER AG NA O.N./ DE000BAY0017 /
| 2024-04-16 5:44:53 PM | Chg. -0.380 | Volume | Bid2024-04-16 | Ask5:44:53 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 26.080EUR | -1.44% | 3.3 mill. Turnover: 86.2 mill. |
-Bid Size: - | -Ask Size: - | 25.83 bill.EUR | 0.42% | - |
GlobeNewswire
9:12 PM
Bayer US President Sebastian Guth to Serve as Honorary Chair for UNCF NJ 80th Anniversary Masked Bal...
GlobeNewswire
2:03 PM
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
04-11
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
03-25
BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire
03-06
BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
GlobeNewswire
03-04
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
GlobeNewswire
02-15
2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire
02-13
Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire
02-13
First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure
GlobeNewswire
01-05
AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)
GlobeNewswire
01-04
AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary end...
GlobeNewswire
2023-12-14
Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Su...
GlobeNewswire
2023-12-06
NFWF Announces $4.1 Million in Grants to Conserve the Monarch Butterfly and Other Insect Pollinators
